DK0696275T3 - Vitamin D-amid-derivater - Google Patents

Vitamin D-amid-derivater

Info

Publication number
DK0696275T3
DK0696275T3 DK94914472T DK94914472T DK0696275T3 DK 0696275 T3 DK0696275 T3 DK 0696275T3 DK 94914472 T DK94914472 T DK 94914472T DK 94914472 T DK94914472 T DK 94914472T DK 0696275 T3 DK0696275 T3 DK 0696275T3
Authority
DK
Denmark
Prior art keywords
group
pct
alpha
vitamin
sec
Prior art date
Application number
DK94914472T
Other languages
Danish (da)
English (en)
Inventor
Robert Henry Hesse
Sundara Katugam Srinivas Setty
Malathi Ramgopal
Original Assignee
Res Inst Medicine Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Medicine Chem filed Critical Res Inst Medicine Chem
Application granted granted Critical
Publication of DK0696275T3 publication Critical patent/DK0696275T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94914472T 1993-05-07 1994-05-06 Vitamin D-amid-derivater DK0696275T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309422A GB9309422D0 (en) 1993-05-07 1993-05-07 Chemical compounds
PCT/GB1994/000975 WO1994026707A1 (en) 1993-05-07 1994-05-06 Vitamin d amide derivatives

Publications (1)

Publication Number Publication Date
DK0696275T3 true DK0696275T3 (da) 1998-11-09

Family

ID=10735089

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94914472T DK0696275T3 (da) 1993-05-07 1994-05-06 Vitamin D-amid-derivater

Country Status (20)

Country Link
US (1) US5756733A (de)
EP (1) EP0696275B1 (de)
JP (1) JP3703099B2 (de)
KR (1) KR100321414B1 (de)
CN (1) CN1093852C (de)
AT (1) ATE169617T1 (de)
AU (1) AU678246B2 (de)
CA (1) CA2162272A1 (de)
CZ (1) CZ291238B6 (de)
DE (1) DE69412476T2 (de)
DK (1) DK0696275T3 (de)
ES (1) ES2122275T3 (de)
FI (1) FI112361B (de)
GB (1) GB9309422D0 (de)
HU (1) HUT74165A (de)
IL (1) IL109595A (de)
NO (1) NO309187B1 (de)
NZ (1) NZ265665A (de)
WO (1) WO1994026707A1 (de)
ZA (1) ZA943162B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405715D0 (en) * 1994-03-23 1994-05-11 Res Inst Medicine Chem Chemical compounds
CA2224062C (en) * 1995-06-06 2001-09-04 Pfizer Limited Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
GB9623569D0 (en) * 1996-11-13 1997-01-08 Immunodiagnostic Systems Ltd Vitamin D immumoassay systems
US6043385A (en) * 1997-12-16 2000-03-28 Hoffman-La Roche Inc. Vitamin D derivatives
GB9804861D0 (en) 1998-03-06 1998-04-29 Res Inst Medicine Chem Chemical compounds
EP1123921A4 (de) * 1998-10-23 2003-08-20 Teijin Ltd Vitamin d 3 derivate und diese enthaltende heilmittel für entzündliche erkrankungen der atemwege
EP1152749B1 (de) * 1999-02-08 2006-04-12 ALZA Corporation Stabile nicht wässerige einphasige visköse vehikeln und formulierungen die diese vehikeln verwenden
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
ES2240159T3 (es) 1999-09-29 2005-10-16 Colotech A/S Prevencion del cancer colorrectal.
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US7985744B2 (en) * 2000-06-15 2011-07-26 Chugai Seiyaku Kabushiki Kaisha Vitamin D derivatives
ES2364623T3 (es) * 2000-06-15 2011-09-08 Chugai Seiyaku Kabushiki Kaisha Derivados de vitamina d que poseen un átomo 22-oxa o 22-tia, una cadena lateral c17 sustituida con un grupo ácido, éster o amida y un enlace doble 16(17).
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
RU2323926C2 (ru) * 2000-12-08 2008-05-10 Чугаи Сейяку Кабусики Кайся Способ карбонилирования
CN1649845A (zh) * 2002-04-26 2005-08-03 先灵公司 蝇蕈碱拮抗剂
RU2440980C2 (ru) * 2006-06-02 2012-01-27 Ниппон Синяку Ко., Лтд. 9,10-секопрегнановое производное и фармацевтические средства
WO2009117831A1 (en) * 2008-03-27 2009-10-01 The Royal Institution For The Advancement Of Learning/Mcgill University Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
EA201691980A1 (ru) 2009-01-27 2017-07-31 БЕРГ ЭлЭлСи Способы уменьшения побочных эффектов, связанных с химиотерапией
CN102655869B (zh) 2009-08-14 2016-08-10 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
US9290447B2 (en) 2011-05-03 2016-03-22 Wisconsin Alumni Research Foundation (20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their uses
US8987235B2 (en) 2011-05-17 2015-03-24 Wisconsin Alumni Research Foundation N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses
WO2014194133A1 (en) 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
US9338493B2 (en) 2014-06-30 2016-05-10 Apple Inc. Intelligent automated assistant for TV user interactions
US10548908B2 (en) 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8929059D0 (en) * 1989-12-22 1990-02-28 Leo Pharm Prod Ltd Chemical compounds
EP0614455B1 (de) * 1991-11-07 1996-02-21 Research Institute For Medicine And Chemistry Inc. Amid derivate von vitamin d

Also Published As

Publication number Publication date
WO1994026707A1 (en) 1994-11-24
FI955316A0 (fi) 1995-11-06
CA2162272A1 (en) 1994-11-24
KR100321414B1 (ko) 2002-12-05
JP3703099B2 (ja) 2005-10-05
DE69412476T2 (de) 1999-03-11
CZ290395A3 (en) 1996-06-12
GB9309422D0 (en) 1993-06-23
CN1093852C (zh) 2002-11-06
EP0696275A1 (de) 1996-02-14
HUT74165A (en) 1996-11-28
AU6683294A (en) 1994-12-12
FI955316A7 (fi) 1995-12-22
FI112361B (fi) 2003-11-28
IL109595A0 (en) 1994-08-26
NO954426D0 (no) 1995-11-06
AU678246B2 (en) 1997-05-22
ZA943162B (en) 1995-04-13
CN1125436A (zh) 1996-06-26
ATE169617T1 (de) 1998-08-15
US5756733A (en) 1998-05-26
EP0696275B1 (de) 1998-08-12
IL109595A (en) 1999-04-11
ES2122275T3 (es) 1998-12-16
JPH08509971A (ja) 1996-10-22
HU9503190D0 (en) 1996-01-29
DE69412476D1 (de) 1998-09-17
NZ265665A (en) 1997-05-26
NO954426L (no) 1996-01-08
NO309187B1 (no) 2000-12-27
CZ291238B6 (cs) 2003-01-15

Similar Documents

Publication Publication Date Title
ATE169617T1 (de) Vitamin-d-amid-derivate
IL123701A0 (en) Heterocyclic fungicides
DK0710227T3 (da) Vitamin D-analoger
DE69208478D1 (de) Amid derivate von vitamin d
DE69425980D1 (de) Vitamin d amin- und amidderivate
NO963949D0 (no) Amidderivater av vitamin D
ES2093091T3 (es) Derivado de glutation.
EP1061070A4 (de) 24-hydroxy-vitamin-d-derivate